These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6827693)

  • 1. Possible use of indoramin in patients with chronic neurogenic bladder dysfunction.
    Vaidyanathan S; Rao MS; Sharma PL; Chary KS; Swamy RP
    J Urol; 1983 Jan; 129(1):96-101. PubMed ID: 6827693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indoramin, an alpha blocker, in functional disorders of the lower urinary tract].
    García Ortiz R; Jara O; Barbera A
    Rev Med Chil; 1985 Jan; 113(1):12-7. PubMed ID: 4081378
    [No Abstract]   [Full Text] [Related]  

  • 3. [An electromyographic study of detrusor sphincter dyssynergia in the neurogenic vesical dysfunction. Part 1. Its type and further sub-typing based on the analysis of motor units].
    Shinno Y
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1436-42. PubMed ID: 2601217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outflow obstruction in neuropathic bladder dysfunction: the neuropathic urethra.
    Sunder GS; Parsons KF; Gibbon NO
    Br J Urol; 1978 May; 50(3):190-9. PubMed ID: 753459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of bladder outlet resistance by selective stimulation of the ventral sacral root using high frequency blockade: a chronic study in spinal cord transected dogs.
    Abdel-Gawad M; Boyer S; Sawan M; Elhilali MM
    J Urol; 2001 Aug; 166(2):728-33. PubMed ID: 11458125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the alpha-adrenergic blocking agent thymoxamine on the neurogenic bladder and urethra.
    Pedersen E; Tørring J; Klemar B
    Acta Neurol Scand; 1980 Feb; 61(2):107-14. PubMed ID: 6446830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoramin--an effective new drug in the management of bladder outflow obstruction.
    Iacovou JW; Dunn M
    Br J Urol; 1987 Dec; 60(6):526-8. PubMed ID: 2447995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of sphincter dyssynergia].
    Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1990; 81(13 Suppl):1967-76. PubMed ID: 2131366
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of striated and smooth muscle components in the urethral pressure profile in traumatic neurogenic bladders: a neuropharmacological and urodynamic study. Preliminary report.
    Rossier AB; Fam BA; Lee IY; Sarkarati M; Evans DA
    J Urol; 1982 Sep; 128(3):529-35. PubMed ID: 6126598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential blockade of alpha-adrenoceptors by indoramin.
    Nicholls DP; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Jun; 17(6):719-28. PubMed ID: 6146328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonobstructive posterior urethral widening (spinning top urethra) in boys with bladder instability.
    Saxton HM; Borzyskowski M; Robinson LB
    Radiology; 1992 Jan; 182(1):81-5. PubMed ID: 1727315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urethral supersensitivity and occult urethral neuropathy.
    Parsons KF; Turton MB
    Br J Urol; 1980 Apr; 52(2):131-7. PubMed ID: 7426963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evaluation of alpha-adrenergic blocking agents in children with neurogenic bladder due to myelomeningocele.
    de Voogt HJ; van der Sluis C
    Dev Med Child Neurol Suppl; 1976; (37):82-8. PubMed ID: 797616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An electromyographic study of detrusor sphincter dyssynergia in neurogenic vesical dysfunction. Part 2. Changes after radical transurethral resection of prostate and response to alpha-adrenergic stimulation].
    Shinno Y
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1443-50. PubMed ID: 2574758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of neurogenic bladder in patients with spinal cord injury using a CMG.EMG study and CMG.UFM.EMG study].
    Aoki H; Adachi M; Banya Y; Sakuma Y; Seo K; Kubo T; Ohori T; Takagane H; Suzuki Y
    Hinyokika Kiyo; 1985 Jun; 31(6):937-48. PubMed ID: 4061211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of urethral resistance after the administration of an alpha-adrenoceptor blocking agent, urapidil, for neuropathic voiding dysfunction.
    Yamanishi T; Yasuda K; Tojo M; Hattori T; Sakakibara R; Shimazaki J
    Paraplegia; 1994 Apr; 32(4):271-6. PubMed ID: 7912822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental studies of urinary incontinence. Effect of tiropramide on the urinary stage and evacuation].
    Morita T; Ando M; Hirano S; Dokita S; Kondo S; Tsuchida S
    Nihon Hinyokika Gakkai Zasshi; 1992 Nov; 83(11):1835-40. PubMed ID: 1336080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term trial of an alpha adrenoceptor blocking drug (Indoramin) in asthma. A preliminary report.
    Black JL; Temple DM; Anderson SD
    Scand J Respir Dis; 1978; 59(6):307-12. PubMed ID: 373090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with electromyography of the external urethral sphincter in spinal cord injury patients.
    Koyanagi T; Arikado K; Takamatsu T; Tsuji I
    J Urol; 1982 Feb; 127(2):272-6. PubMed ID: 7062383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
    Mokhless I; Gaafar S; Fouda K; Shafik M; Assem A
    J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.